Scholarly & Creative Works
selected publications
-
Article
-
2022Mortality Trends for Lung Cancer and Smoking Prevalence In PeruFull Text via DOI: 10.31557/APJCP.2022.23.2.435
-
2022The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerFull Text via DOI: 10.1016/j.cllc.2021.08.012 Web of Science: 000751751100012
-
2021Influence of Sex in the Molecular Characteristics and Outcomes of Malignant TumorsFull Text via DOI: 10.3389/fonc.2021.752918 Web of Science: 000715850100001
-
2021Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Full Text via DOI: 10.1016/j.lungcan.2021.08.010 Web of Science: 000702866700014
-
2021Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Full Text via DOI: 10.2217/imt-2021-0019 Web of Science: 000641732500001
-
2021Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 TherapyFull Text via DOI: 10.1158/1078-0432.CCR-20-3305 Web of Science: 000620168400017
-
2020Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)Full Text via DOI: 10.1016/j.jclinepi.2020.05.033 Web of Science: 000576195200001
-
2020Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA StandardsFull Text via DOI: 10.1200/JCO.19.02297 Web of Science: 000517176600014
-
2020Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancerFull Text via DOI: 10.1080/17476348.2020.1721285 Web of Science: 000511643400001
-
2019Current knowledge of Ipilimumab and its use in treating non-small cell lung cancerFull Text via DOI: 10.1080/14712598.2019.1610380 Web of Science: 000476931600003
-
2018Exosome-Based Detection of EGFR T790M in Plasma from Non-Small Cell Lung Cancer PatientsFull Text via DOI: 10.1158/1078-0432.CCR-17-3369 Web of Science: 000435462700024
-
2018Making Sense of Immunotherapy in Lung Cancer: What the Pulmonologist Needs to Know?Full Text via DOI: 10.1007/s13665-018-0200-9 Web of Science: 000433116800002
-
2018Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenFull Text via DOI: 10.1056/NEJMoa1714448 Web of Science: 000425613900010
-
2017Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaFull Text via DOI: 10.1016/j.cllc.2016.05.003 Web of Science: 000504053200009
-
2016Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patientsFull Text via DOI: 10.21037/tcr.2016.12.14 Web of Science: 000393329400035
-
2015Entinostat (SNDX-275) for the treatment of non-small cell lung cancerFull Text via DOI: 10.1517/13543784.2015.1056779 Web of Science: 000358751200010
-
2014Immunotherapeutic Agents in Non-small-cell Lung Cancer Finally Coming to the Front LinesFull Text via DOI: 10.1007/s11912-014-0400-6 Web of Science: 000341081600005
-
2014The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFR-Inhibitors: Did We Really Find the Target?Full Text via DOI: 10.2174/138945011514141216092739 Web of Science: 000346421300004
-
2009Developing a vaccine for non-small-cell lung cancerFull Text via DOI: 10.3810/pgm.2009.09.2067
-
2007Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerFull Text via DOI: 10.1056/NEJMoa070956
-
1999Pulmonary bone marrow embolism in sickle cell diseaseFull Text via DOI: 10.1097/00007611-199902000-00018
-
-
Conference
-
2021Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. 2577-2584.Full Text via DOI: 10.1158/1535-7163.MCT-21-0201 Web of Science: 000728361200001
-
2016"Real World" Use of Liquid Biopsy in Patients With Lung Adenocarcinoma and Correlation With Tumor Tissue Genetic Profile. S199-S200.Full Text via DOI: 10.1016/j.jtho.2016.08.051 Web of Science: 000427345100045
-
2016Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar. S187-S188.Full Text via DOI: 10.1016/j.jtho.2016.08.035 Web of Science: 000427345100029
-
2016Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar. S176-S176.Full Text via DOI: 10.1016/j.jtho.2016.08.016 Web of Science: 000427345100012
-
2015Genomic Analysis of Lung Cancer Tumors from Hispanic Patients Living in the US. S232-S232.Web of Science: 000370365100384
-
-
Editorial Material
-
2018Old myths about old patients: The case of non-small cell lung cancer. S362-S363.Full Text via DOI: 10.21037/TLCR.2018.09.24
-
2009Cancer vaccines: A new therapeutic alternative for lung cancer therapy?. 727-728.Full Text via DOI: 10.2217/IMT.09.57
-
Letter
-
2020Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant. E640-E642.Full Text via DOI: 10.1097/MJT.0000000000001133 Web of Science: 000619165200020
-
2018Regarding the Congruence between 2 Circulating Tumor DNA Sequencing Assays. 1430.Full Text via DOI: 10.1001/jamaoncol.2018.2320
-
2018ROS-1 Rearrangements in Circulating Tumor Cells. E71-E72.Full Text via DOI: 10.1016/j.jtho.2017.11.127 Web of Science: 000432452900001
-
2018EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?. e33-e34.Full Text via DOI: 10.1016/j.jtho.2017.10.005
-
2017Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping. e89-e90.Full Text via DOI: 10.1016/j.jtho.2017.02.017
-
2005Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer [10]. 4244-4245.Full Text via DOI: 10.1200/JCO.2004.00.5165
-
-
Other Scholarly Work
-
2020Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps. 535-538.Full Text via DOI: 10.1016/j.jaccao.2020.06.009 Web of Science: 000613114400027
-
2020Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy. 784-788.Full Text via DOI: 10.1200/GO.20.00004 Web of Science: 000556801700003
-
2018Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trial. 6388-6391.Full Text via DOI: 10.21037/jtd.2018.11.22 Web of Science: 000456834700030
-
2018Tumor Type-Agnostic Treatment and the Future of Cancer Therapy. 541-544.Full Text via DOI: 10.1007/s11523-018-0593-y Web of Science: 000446890500001
-
2018Moving osimertinib to first-line: the right "strategy" in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?. S1076-S1080.Full Text via DOI: 10.21037/jtd.2018.03.92 Web of Science: 000431688000029
-
2016Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer. 1-4.Full Text via DOI: 10.2217/lmt-2016-0003 Web of Science: 000374006000001
-
Review
-
2021Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer. 1165-1178.Full Text via DOI: 10.1080/14737159.2021.1985468 Web of Science: 000707822000001
-
2021Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung CancerFull Text via DOI: 10.3390/cancers13205038 Web of Science: 000714000600001
-
2021Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care?. 1229-1235.Full Text via DOI: 10.1080/14737140.2021.1982387 Web of Science: 000699890100001
-
2021Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer. 1647-1662.Full Text via DOI: 10.1016/j.jtho.2021.06.017 Web of Science: 000701853900008
-
2021Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer: Evidence to date. 192-198.Full Text via DOI: 10.1016/j.hemonc.2020.11.005
-
2021Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingFull Text via DOI: 10.1007/s11912-021-01059-1 Web of Science: 000640506800004
-
2020Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy. 1635-1644.Full Text via DOI: 10.1158/2159-8290.CD-20-0466 Web of Science: 000583736200020
-
2020A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation. 2113-2119.Full Text via DOI: 10.21037/tlcr-20-601 Web of Science: 000582799700040
-
2020Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countriesFull Text via DOI: 10.1177/1753466620938553 Web of Science: 000551965800001
-
2019The value of immunotherapy in head and neck cancer. 35-43.Full Text via DOI: 10.1080/14712598.2019.1556637 Web of Science: 000454640500002
-
2018Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment. 259-268.Full Text via DOI: 10.1016/j.semcancer.2018.01.015 Web of Science: 000446285900027
-
2018Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. 1248-1268.Full Text via DOI: 10.1016/j.jtho.2018.05.030 Web of Science: 000444520200018
-
2018Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression. 175-187.Full Text via DOI: 10.1007/s11523-018-0551-8 Web of Science: 000429367900005
-
2017New targets bring hope in squamous cell lung cancer: Neurotrophic tyrosine kinase gene fusions. 1268-1270.Full Text via DOI: 10.1038/labinvest.2017.91
-
2017The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer. 7-12.Full Text via DOI: 10.4081/oncol.2017.324
-
2016BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?. 32-39.Full Text via DOI: 10.1016/j.critrevonc.2016.02.012 Web of Science: 000376218000004
-
2016The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. 385-392.Full Text via DOI: 10.1517/13543784.2016.1152261 Web of Science: 000372076200003
-
2015Entrectinib: A potent new TRK, ROS1, and ALK inhibitor. 1493-1500.Full Text via DOI: 10.1517/13543784.2015.1096344
-
2015Nintedanib in non-small cell lung cancer: From preclinical to approval. 164-172.Full Text via DOI: 10.1177/1753465815579608
-
2015cMET in NSCLC: Can we cut off the head of the Hydra? From the pathway to the resistance. 556-573.Full Text via DOI: 10.3390/cancers7020556
-
2014Immunotherapy: Is a minor god yet in the pantheon of treatments for lung cancer?. 1173-1187.Full Text via DOI: 10.1586/14737140.2014.952287
-
2014Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors. 990-1004.Full Text via DOI: 10.1016/j.ctrv.2014.05.009 Web of Science: 000340851900011
-
2014ALK and crizotinib: after the honeymoon... what else? Resistance mechanisms and new therapies to overcome it. 250-261.Full Text via DOI: 10.3978/j.issn.2218-6751.2014.03.01 Web of Science: 000218826600008
-
2014Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor. 15-26.Full Text via DOI: 10.1517/14712598.2013.843667 Web of Science: 000328109400004
-
2013Targeting angiogenesis in non-small-cell lung cancer: A focus on current approaches and future developments. 503-517.Full Text via DOI: 10.2217/cpr.13.27
-
2012Emerging role of multikinase inhibitors for refractory thyroid cancer. 257-265.Full Text via DOI: 10.2147/BTT.S24465
-
2012Immunotherapy for nonsmall-cell lung cancer. 90-93.Full Text via DOI: 10.1007/s12254-012-0019-y Web of Science: 000219607500004
-
2012Novel molecular targeted therapies for refractory thyroid cancer. 736-745.Full Text via DOI: 10.1002/hed.21755
-
2012Epidermal growth factor vaccine in non-small-cell lung cancer. 439-445.Full Text via DOI: 10.1586/ERA.12.24 Web of Science: 000303228800009
-
2011Active immunotherapy for non-small-cell lung cancer: Moving toward a reality. 1599-1605.Full Text via DOI: 10.1586/era.11.155
-
2011The role of proteasome inhibition in nonsmall cell lung cancerFull Text via DOI: 10.1155/2011/806506
-
2011Development of targeted therapy for squamous cell carcinomas of the head and neck. 373-386.Full Text via DOI: 10.1586/era.10.193
-
2011Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. 43-54.Full Text via DOI: 10.2217/thy.10.84
-
2010EGF receptor in lung cancer: A successful story of targeted therapy. 1577-1587.Full Text via DOI: 10.1586/era.10.141
-
2010Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art. 105-112.Full Text via DOI: 10.1016/j.smim.2010.02.001
-
2010Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC. 549-557.Full Text via DOI: 10.1586/era.10.30
-
2010Nasopharyngeal carcinoma: Alternative treatment options after disease progression. 377-386.Full Text via DOI: 10.1586/ERA.10.1
-
2010Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer. 18-24.Full Text via DOI: 10.3816/CLC.2010.n.003
-
2009How is gene-expression profiling going to challenge the future management of lung cancer?. 827-835.Full Text via DOI: 10.2217/fon.09.60
-
2009Epidermal growth factor receptor pathway as therapeutic development in head and neck cancers: Present and future. 137-148.Full Text via DOI: 10.1007/s12156-009-0022-7
-
2009Gene expression profiling and non-small-cell lung cancer: Where are we now?. 168-173.Full Text via DOI: 10.3816/CLC.2009.n.023
-
2009Second-line therapy for non-small-cell lung cancer. 91-98.Full Text via DOI: 10.3816/CLC.2009.n.011
-
2008Controversies in the management of stage IIIA non-small-cell lung cancer. 1913-1929.Full Text via DOI: 10.1586/14737140.8.12.1913
-
2008Targeting important pathways in head and neck cancer: From the bench to the clinic. 1819-1835.Full Text via DOI: 10.1586/14737140.8.11.1819
-
2007Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96. 1679-1688.Full Text via DOI: 10.1517/14712598.7.11.1679
-
2007New targets for non-small-cell lung cancer therapy. 1423-1437.Full Text via DOI: 10.1586/14737140.7.10.1423
-
2006Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma. 2453-2476.Full Text via DOI: 10.1080/10428190600923140
-
2006Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. 1205-1215.Full Text via DOI: 10.1586/14737140.6.9.1205
-
2006Present and future of lung cancer vaccines. 445-459.Full Text via DOI: 10.1517/14728214.11.3.445
-
2006Heat Shock Protein-Based Cancer Vaccines. 637-659.Full Text via DOI: 10.1016/j.hoc.2006.02.007
-
2006New developments in chemotherapy for advanced non-small cell lung cancer. 156-161.Full Text via DOI: 10.1097/01.cco.0000208789.37689.6b
-
2005Clinical trials targeting lung cancer with active immunotherapy: The scope of vaccines. 635-644.Full Text via DOI: 10.1586/14737140.5.4.635
-
2005DNA methylation: Its role in lung carcinogenesis and therapeutic implications. 667-679.Full Text via DOI: 10.1586/14737140.5.4.667
-
2005Combined modality therapy for limited-disease Small Cell Lung Cancer. 69-74.Full Text via DOI: 10.1007/s11864-005-0014-1
-
2004
-
